Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 11-Jun-24 4:51 PM View:  | BioSante Pharmaceuticals, I... (ANIP) | 07-Jun-24 | Payment of Exercise | 11,087 | $67.70 | $750,590.00 | (9%) 128.92K to 117.83K | |
| 11-Jun-24 4:51 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 07-Jun-24 | Option Exercise | 12,550 | $52.70 | $661,366.00 | 11% 116.37K to 128.92K | |
| 11-Apr-24 9:13 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 10-Apr-24 | Payment of Exercise | 2,799 | $66.96 | $187,421.00 | (2%) 118.81K to 116.01K | |
| 25-Mar-24 4:14 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 23-Mar-24 | Payment of Exercise | 3,653 | $69.58 | $254,176.00 | (3%) 122.46K to 118.81K | |
| 07-Mar-24 9:42 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 07-Mar-24 | Payment of Exercise | 2,034 | $66.71 | $135,688.00 | (1%) 148.83K to 146.8K | |
| 07-Mar-24 9:42 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 07-Mar-24 | Sale | 24,338 | $66.37 | $1,615,310.00 | (17%) 146.8K to 122.46K | |
| 01-Mar-24 5:09 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 29-Feb-24 | Payment of Exercise | 1,058 | $67.67 | $71,594.90 | (< 1%) 149.89K to 148.83K | |
| 16-Feb-24 4:47 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 14-Feb-24 | Grant | 16,776 | -- | -- | 13% 133.11K to 149.89K | |
| 25-Aug-23 4:17 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 23-Aug-23 | Option Exercise | 5,417 | $38.25 | $207,224.00 | 4% 131.63K to 137.04K | |
| 25-Aug-23 4:17 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 23-Aug-23 | Option Sale | 3,932 | $63.00 | $247,716.00 | (3%) 137.04K to 133.11K | |
| 12-Apr-23 4:42 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 10-Apr-23 | Payment of Exercise | 2,289 | $38.50 | $88,126.50 | (2%) 133.92K to 131.63K | (13%) |
| 30-Mar-23 8:01 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 28-Mar-23 | Payment of Exercise | 524 | $38.62 | $20,236.90 | (< 1%) 112.73K to 112.21K | (13%) |
| 27-Mar-23 8:02 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 23-Mar-23 | Payment of Exercise | 2,452 | $37.82 | $92,734.60 | (2%) 115.18K to 112.73K | |
| 09-Mar-23 4:36 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 07-Mar-23 | Payment of Exercise | 2,460 | $44.23 | $108,806.00 | (2%) 117.64K to 115.18K | 2% |
| 04-Apr-23 8:06 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 28-Feb-23 | Grant | 21,710 | -- | -- | 19% 112.21K to 133.92K | |
| 16-Aug-22 9:01 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 15-Aug-22 | Sale | 5,172 | $37.79 | $195,464.00 | (4%) 122.81K to 117.64K | |
| 16-Aug-22 9:01 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 12-Aug-22 | Sale | 12,894 | $37.04 | $477,605.00 | (10%) 135.71K to 122.81K | |
| 29-Apr-22 6:35 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 27-Apr-22 | Grant | 6,644 | -- | -- | 5% 129.06K to 135.71K | |
| 12-Apr-22 5:13 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 10-Apr-22 | Payment of Exercise | 1,878 | $29.91 | $56,171.00 | (1%) 130.94K to 129.06K | |
| 08-Apr-22 5:36 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 06-Apr-22 | Payment of Exercise | 337 | $29.69 | $10,005.50 | (< 1%) 131.28K to 130.94K | |
| 30-Mar-22 4:13 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 28-Mar-22 | Payment of Exercise | 524 | $28.17 | $14,761.10 | (< 1%) 131.8K to 131.28K | |
| 28-Mar-22 8:49 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 24-Mar-22 | Grant | 19,934 | -- | -- | 18% 111.87K to 131.8K | |
| 25-Mar-22 8:56 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 23-Mar-22 | Payment of Exercise | 2,452 | $27.03 | $66,277.60 | (2%) 114.32K to 111.87K | |
| 13-Apr-21 5:26 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 12-Apr-21 | Payment of Exercise | 1,878 | $31.86 | $59,833.10 | (2%) 116.2K to 114.32K | (2%) |
| 07-Apr-21 8:29 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 06-Apr-21 | Payment of Exercise | 337 | $33.69 | $11,353.50 | (< 1%) 116.54K to 116.2K | (< 1%) |
| 31-Mar-21 8:57 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 31-Mar-21 | Payment of Exercise | 278 | $36.14 | $10,046.90 | (< 1%) 116.81K to 116.54K | |
| 31-Mar-21 8:57 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 29-Mar-21 | Payment of Exercise | 524 | $32.68 | $17,124.30 | (< 1%) 117.34K to 116.81K | (< 1%) |
| 25-Mar-21 4:45 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 23-Mar-21 | Grant | 32,041 | -- | -- | 38% 85.3K to 117.34K | |
| 14-Apr-20 4:31 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 10-Apr-20 | Grant | 24,548 | -- | -- | 40% 60.75K to 85.3K | |
| 08-Apr-20 5:53 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 07-Apr-20 | Payment of Exercise | 144 | $43.93 | $6,325.92 | (< 1%) 60.89K to 60.75K | |
| 08-Apr-20 5:53 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 06-Apr-20 | Payment of Exercise | 337 | $43.22 | $14,565.10 | (< 1%) 61.23K to 60.89K | |
| 20-May-19 4:32 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 17-May-19 | Market Sale | 8,907 | $70.67 | $629,458.00 | (13%) 70.14K to 61.23K | 1% |
| 15-May-19 4:32 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 14-May-19 | Market Sale | 4,917 | $70.31 | $345,714.00 | (7%) 75.05K to 70.14K | < 1% |
| 18-Apr-19 4:33 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 16-Apr-19 | Payment of Exercise | 115 | $68.60 | $7,889.00 | (< 1%) 75.17K to 75.05K | (3%) |
| 09-Apr-19 4:45 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 07-Apr-19 | Payment of Exercise | 144 | $70.50 | $10,152.00 | (< 1%) 75.31K to 75.17K | (< 1%) |
| 09-Apr-19 4:45 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 06-Apr-19 | Payment of Exercise | 337 | $70.50 | $23,758.50 | (< 1%) 75.65K to 75.31K | (< 1%) |
| 02-Apr-19 4:46 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 31-Mar-19 | Payment of Exercise | 278 | $70.54 | $19,610.10 | (< 1%) 75.93K to 75.65K | (< 1%) |
| 01-Apr-19 4:02 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 28-Mar-19 | Grant | 6,848 | -- | -- | 10% 69.08K to 75.93K | |
| 24-May-18 4:01 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 22-May-18 | Payment of Exercise | 253 | $61.88 | $15,655.60 | (< 1%) 69.33K to 69.08K | (14%) |
| 18-Apr-18 4:34 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 16-Apr-18 | Payment of Exercise | 115 | $60.21 | $6,924.15 | (< 1%) 69.45K to 69.33K | (17%) |
| 10-Apr-18 5:26 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 07-Apr-18 | Payment of Exercise | 144 | $57.06 | $8,216.64 | (< 1%) 69.59K to 69.45K | (24%) |
| 10-Apr-18 5:26 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 06-Apr-18 | Grant | 4,400 | -- | -- | 7% 65.19K to 69.59K | |
| 03-Apr-18 5:14 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 31-Mar-18 | Payment of Exercise | 278 | $58.22 | $16,185.20 | (< 1%) 65.47K to 65.19K | (21%) |
| 07-Mar-18 5:00 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 05-Mar-18 | Option Exercise | 18,001 | $11.11 | $199,947.00 | 35% 51.65K to 69.65K | |
| 07-Mar-18 5:00 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 05-Mar-18 | Market Option Sale | 4,177 | $61.92 | $258,640.00 | (6%) 69.65K to 65.47K | (14%) |
| 24-May-17 4:30 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 22-May-17 | Payment of Exercise | 278 | $47.01 | $13,068.80 | (< 1%) 51.83K to 51.55K | (50%) |
| 04-Apr-17 6:03 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 31-Mar-17 | Grant | 3,625 | -- | -- | 8% 48.2K to 51.83K | |
| 11-Apr-16 7:03 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 07-Apr-16 | Grant | 1,875 | -- | -- | 4% 45.98K to 47.86K | |
| 22-Dec-15 4:23 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 18-Dec-15 | Market Sale | 3,500 | $43.26 | $151,410.00 | (7%) 49.48K to 45.98K | (63%) |
| 20-Jul-15 4:30 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 17-Jul-15 | Option Exercise | 7,395 | $6.36 | $47,032.20 | 18% 42.09K to 49.48K |